2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Asymptomatic Infections: new trials by email Literature Review of Asymptomatic Infections trials Research Report on Asymptomatic Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization Resistant Potato Starch, Maltodextrin - Clostridium Infections, Methicillin-resistant Staphylococcus Aureus (MRSA) | Phase 2 | Not yet recruiting | VA Office of Research and Development | 120 | 2027-01-01 | 2026-08-28 |
| Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization lyophilized FMT capsules, Placebo capsules - Colonization, Asymptomatic | Phase 1 / Phase 2 | Recruiting | University of Rijeka | 52 | 2025-07-28 | 2026-10-27 |
| Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2) M5717 60 mg, Pyronaridine, Atovaquone-Proguanil - Malaria Infection | Phase 2 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 192 | 2023-11-28 | 2026-02-06 |
| A Randomized Control Trial of Antibiotic Treatment Duration For Asymptomatic Bacteriuria After Kidney Transplantation 7 days course of antibiotic treatment, 14 days course of antibiotic treatment - Kidney Transplantation, Bacteriuria | Phase 2 | Completed | Mahidol University | 20 | 2015-02-01 | 2016-03-16 |
Bacteriuria (1) · Clostridium Infections (1) · Malaria (1) · Malaria, Falciparum (1)
Asymptomatic Diseases (4) · Disease Attributes (4) · Infections (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gram-Positive Bacterial Infections (1) · Male Urogenital Diseases (1) · Mosquito-Borne Diseases (1) · Parasitic Diseases (1) · Protozoan Infections (1) · Urinary Tract Infections (1)
atovaquone, proguanil drug combination (1) · maltodextrin (1) · pyronaridine (1)
Mahidol University (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · University of Rijeka (1) · VA Office of Research and Development (1)
Burkina Faso (1) · Croatia (1) · Kenya (1) · Thailand (1) · The Gambia (1) · United States (1) · Zambia (1)
Nasia Safdar, MD PhD (1) · Pattraporn Ponglorpisit, MD (1)